Home / MAN1A1 Knockout Cell Lines

MAN1A1 Knockout Cell Lines

Gene: MAN1A1

Official Full Name: mannosidase alpha class 1A member 1provided by HGNC

Gene Summary: This gene encodes a class I mammalian Golgi 1,2-mannosidase which is a type II transmembrane protein. This protein catalyzes the hydrolysis of three terminal mannose residues from peptide-bound Man(9)-GlcNAc(2) oligosaccharides and belongs to family 47 of glycosyl hydrolases. [provided by RefSeq, Jul 2012]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO36713 MAN1A1 Knockout cell line (HeLa) Human MAN1A1 1:3~1:6 Negative Online Inquiry
KO36714 MAN1A1 Knockout cell line (HCT 116) Human MAN1A1 1:2~1:4 Negative Online Inquiry
KO36715 MAN1A1 Knockout cell line (HEK293) Human MAN1A1 1:3~1:6 Negative Online Inquiry

Background

MAN1A1 Gene Knockout Cell Lines represent a specialized set of genetically modified cells in which the MAN1A1 gene, encoding a critical enzyme involved in glycan processing, has been inactivated. By employing CRISPR/Cas9 technology for precise genetic editing, these cell lines serve as invaluable tools for researchers aiming to deepen their understanding of glycosylation processes, cellular signaling, and the role of glycoproteins in various biological phenomena.

The primary function of these cell lines lies in their ability to aid in the investigation of MAN1A1's role in health and disease, particularly in cancer and metabolic disorders. The knockout of the MAN1A1 gene disrupts normal glycan structures, leading to distinct phenotypic changes that can be meticulously analyzed. This allows researchers to dissect the downstream effects on cellular behavior, immune responses, and interactions with other biomolecules, thereby providing insights into the complex regulatory networks governing cellular function.

The scientific importance of MAN1A1 Gene Knockout Cell Lines is substantial, as they open avenues for research into novel therapeutic strategies targeting glycosylation-related diseases. In clinical settings, the understanding gained from these models can translate into the development of biomarker assays, targeted drug design, and personalized medicine approaches based on the glycan profile of tumors.

What sets our MAN1A1 Gene Knockout Cell Lines apart from similar offerings is our commitment to quality and reproducibility. Each line is rigorously validated for genetic integrity, functionality, and physiological relevance, ensuring reliability in experimental outcomes. Furthermore, our expert technical support and detailed usage protocols assist researchers in optimizing their experimental designs, enhancing the likelihood of successful applications.

In summary, the MAN1A1 Gene Knockout Cell Lines provide researchers and clinicians with a powerful tool for exploring the intricate roles of glycosylation, fostering advancements in both fundamental research and clinical applications. Our company, with its extensive expertise in genetic engineering and cell line development, is dedicated to providing high-quality biological products that empower scientific discovery.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.